molmed

Investors

Update on the timing for the approval of ACG Offer Document

Update on the timing for the approval of ACG Offer Document ▾

News & Eventi

Stay update

The Shareholders’ meeting approved the 2019 Financial Statement. ▾

Investors

Shareholders meeting April 27 2020: Guide to the online filing and transmission of the proxy to Computershare S.p.A. (RECOMMENDED PROCEDURE)

Shareholders meeting April 27 2020: Guide to the online filing and transmission of the proxy to Computershare S.p.A. (RECOMMENDED PROCEDURE) ▾

Investors

The Board of Directors, based on the scientific evidence from the experiments on early-stage pre-clinical products, decided to suspend the investments in these projects.

The Board of Directors, based on the scientific evidence from the experiments on early-stage pre-clinical products, decided to suspend the investments in these projects. ▾

Investors

Suspension of the terms of the administrative procedures extended until 15 May 2020 by Decree Law no. 23 of 8 April 2020

Suspension of the terms of the administrative procedures extended until 15 May 2020 by Decree Law no. 23 of 8 April 2020 ▾

Investors

Notice of publication of the Annual Report 2019 and other documents for the Shareholders’ meeting on April 27th, 2020.

Notice of publication of the Annual Report 2019 and other documents for the Shareholders’ meeting on April 27th, 2020. ▾

Governance

2020 Annual Report on remuneration (in Italian) ▾

2020 Annual Report on remuneration (in Italian)

Governance

Report on corporate governance and ownership structure 2020 (in Italian) ▾

Report on corporate governance and ownership structure 2020 (in Italian)

Investors

OFFER DOCUMENT of AGC FILED WITH CONSOB

OFFER DOCUMENT of AGC FILED WITH CONSOB ▾

Investors

Corporate bylaw update

Corporate bylaw update ▾

Subscribe to press releases

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.